Hutchison, CA;
Cockwell, P;
Moroz, V;
Bradwell, AR;
Fifer, L;
Gillmore, JD;
Jesky, MD;
... Cook, M; + view all
(2019)
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
Lancet Haematology
, 6
(4)
e217-e228.
10.1016/S2352-3026(19)30014-6.